Progyny Stock Performance
| PGNY Stock | USD 22.98 0.04 0.17% |
Progyny has a performance score of 1 on a scale of 0 to 100. The company holds a Beta of 0.84, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Progyny's returns are expected to increase less than the market. However, during the bear market, the loss of holding Progyny is expected to be smaller as well. Progyny right now holds a risk of 2.78%. Please check Progyny potential upside, as well as the relationship between the accumulation distribution and period momentum indicator , to decide if Progyny will be following its historical price patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Progyny are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Progyny is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return 0.17 | Five Day Return (0.52) | Year To Date Return 29.61 | Ten Year Return 44.17 | All Time Return 44.17 |
1 | Progyny Inc Q1 2025 Earnings Call Highlights Record Revenue Growth and Strategic Expansions | 05/09/2025 |
2 | Disposition of 1848 shares by Mark Livingston of Progyny at 21.5 subject to Rule 16b-3 | 06/02/2025 |
3 | Disposition of 7977 shares by Michael Sturmer of Progyny at 21.98 subject to Rule 16b-3 | 06/04/2025 |
4 | Progyny Joins Amazons Health Benefits Connector Program as First Womens Health and Family ... | 06/10/2025 |
5 | Disposition of 2675 shares by Scott Cheryl of Progyny at 22.07 subject to Rule 16b-3 | 06/11/2025 |
6 | Acquisition by Cohen Fred E of 6176 shares of Progyny subject to Rule 16b-3 | 06/18/2025 |
7 | Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Womens Health | 06/24/2025 |
8 | Disposition of 7977 shares by Peter Anevski of Progyny at 22.0 subject to Rule 16b-3 | 07/01/2025 |
9 | Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 ... | 07/08/2025 |
10 | Progyny Upgraded by Leerink Partnrs to Strong-Buy Rating | 07/09/2025 |
11 | Progyny Partners with URA to Empower Women and Their Care Teams with Wearable Tech Data, ... | 07/10/2025 |
12 | Progyny Price Target Increased Amid Mixed Investor Sentiment PGNY Stock News | 07/17/2025 |
13 | Why Progyny Stock Is Falling Today | 07/18/2025 |
14 | Why Progyny Stock Is Up Today | 07/21/2025 |
| Begin Period Cash Flow | 97.3 M | |
| Total Cashflows From Investing Activities | 195.8 M |
Progyny Relative Risk vs. Return Landscape
If you would invest 2,290 in Progyny on April 24, 2025 and sell it today you would earn a total of 8.00 from holding Progyny or generate 0.35% return on investment over 90 days. Progyny is currently generating 0.0431% in daily expected returns and assumes 2.7786% risk (volatility on return distribution) over the 90 days horizon. In different words, 24% of stocks are less volatile than Progyny, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Progyny Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Progyny's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Progyny, and traders can use it to determine the average amount a Progyny's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0155
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PGNY |
Estimated Market Risk
| 2.78 actual daily | 24 76% of assets are more volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Progyny is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Progyny by adding it to a well-diversified portfolio.
Progyny Fundamentals Growth
Progyny Stock prices reflect investors' perceptions of the future prospects and financial health of Progyny, and Progyny fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Progyny Stock performance.
| Return On Equity | 0.1 | ||||
| Return On Asset | 0.0599 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 1.74 B | ||||
| Shares Outstanding | 85.72 M | ||||
| Price To Earning | 37.91 X | ||||
| Price To Book | 4.22 X | ||||
| Price To Sales | 1.62 X | ||||
| Revenue | 1.17 B | ||||
| Gross Profit | 266.75 M | ||||
| EBITDA | 67.45 M | ||||
| Net Income | 54.34 M | ||||
| Cash And Equivalents | 122.39 M | ||||
| Cash Per Share | 1.33 X | ||||
| Total Debt | 19.27 M | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 2.46 X | ||||
| Book Value Per Share | 5.49 X | ||||
| Cash Flow From Operations | 179.1 M | ||||
| Earnings Per Share | 0.57 X | ||||
| Market Capitalization | 1.97 B | ||||
| Total Asset | 607.1 M | ||||
| Retained Earnings | 144.31 M | ||||
| Working Capital | 304.09 M | ||||
About Progyny Performance
Evaluating Progyny's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Progyny has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Progyny has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.09 | 0.10 | |
| Return On Capital Employed | 0.15 | 0.16 | |
| Return On Assets | 0.09 | 0.09 | |
| Return On Equity | 0.13 | 0.14 |
Things to note about Progyny performance evaluation
Checking the ongoing alerts about Progyny for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Progyny help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Progyny is unlikely to experience financial distress in the next 2 years | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from stockstory.org: Why Progyny Stock Is Up Today |
- Analyzing Progyny's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Progyny's stock is overvalued or undervalued compared to its peers.
- Examining Progyny's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Progyny's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Progyny's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Progyny's stock. These opinions can provide insight into Progyny's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Progyny Stock Analysis
When running Progyny's price analysis, check to measure Progyny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progyny is operating at the current time. Most of Progyny's value examination focuses on studying past and present price action to predict the probability of Progyny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Progyny's price. Additionally, you may evaluate how the addition of Progyny to your portfolios can decrease your overall portfolio volatility.